Skip to content

Live Events
Sign Up / Login

Live Events
Sign Up / Login

Plus Library

By pinki@katapult.biz / February 13, 2025

Speciality

Author / Speaker

Title of Presentation

Type of Media

Event

2024 Event

Clear

Displaying 2,051 - 2,075 of 2,875

«
1
…
81
82
83
84
85
…
115
»

Targeted Therapies in Lung Cancer

Targeted Therapies in Lung Cancer

Sami Diab, MD

Squamous NSCLC and Small Cell Lung Cancer Update

Squamous NSCLC and Small Cell Lung Cancer Update

Sandip Patel, MD

Combination Immunotherapy for Lung Cancer

Combination Immunotherapy for Lung Cancer

Scott Antonia, MD, PhD

Mesothelioma and Thymoma – Limited and Advanced Stage

Mesothelioma and Thymoma – Limited and Advanced Stage

Shiruyeh Schokrpur, MD, PhD

Mesothelioma and Thymoma – Limited and Advanced Stage

Mesothelioma and Thymoma – Limited and Advanced Stage

Shiruyeh Schokrpur, MD, PhD

Immunotherapy in Neoadjuvant - Adjuvant &Stage III NSCLC

Immunotherapy in Neoadjuvant - Adjuvant &Stage III NSCLC

Solivan, Pedro

Uncommon Mutations/ Fusions: EGFRex20, RET, MET, HER2, NRG1

Uncommon Mutations/ Fusions: EGFRex20, RET, MET, HER2, NRG1

Stephen Liu, MD

Novel Mechanisms of Resistance Identified for Tyrosine Kinakse Inhibitors against ALk and Ros1 Tumors in NSCLC

Novel Mechanisms of Resistance Identified for Tyrosine Kinakse Inhibitors against ALk and Ros1 Tumors in NSCLC

Stephen Liu, MD

Novel Mechanisms of Resistance Identified for Tyrosine Kinakse Inhibitors against ALk and Ros1 Tumors in NSCLC

Novel Mechanisms of Resistance Identified for Tyrosine Kinakse Inhibitors against ALk and Ros1 Tumors in NSCLC

Stephen Liu, MD

TROP-2 and AXL as Targets in NSCLC

TROP-2 and AXL as Targets in NSCLC

Stephen Liu, MD

TROP-2 and AXL as Targets in NSCLC

TROP-2 and AXL as Targets in NSCLC

Stephen Liu, MD

Uncommon Mutations/Fusions: EGFRex20ins, RET, MET, Her2, NRG1

Uncommon Mutations/Fusions: EGFRex20ins, RET, MET, Her2, NRG1

Stephen V. Liu, MD

Uncommon Mutations/Fusions: EGFRex20ins, RET, MET, Her2, NRG1

Uncommon Mutations/Fusions: EGFRex20ins, RET, MET, Her2, NRG1

Stephen V. Liu, MD

Approach to lung cancer in the UK

Approach to lung cancer in the UK

Steve Bandula, MD, PhD

Locally Advanced NSCLC- Radiation Therapy

Locally Advanced NSCLC- Radiation Therapy

Sue Yom, MD, PhD

Locally Advanced NSCLC-Radiation Therapy

Locally Advanced NSCLC-Radiation Therapy

Sue Yom, MD, PhD

Locally Advanced NSCLC- Radiation Therapy

Locally Advanced NSCLC- Radiation Therapy

Sue Yom, MD, PhD

Session II - Locally Advanced Non-Small Cell Lung CancerPathology and Biology

Session II - Locally Advanced Non-Small Cell Lung CancerPathology and Biology

Sue Yom, MD, PhD, Primo Lara, Jr, MD, Leah Backhus, MD, Tianhong “Tina” Li, MD, PhD

Immunotherapy for Advanced Non-Small Cell Lung Cancer

Immunotherapy for Advanced Non-Small Cell Lung Cancer

Sukhmani K Padda

Small Cell Lung Cancer Novel Approaches

Small Cell Lung Cancer Novel Approaches

Sukhmani K. Padda, MD

Immunotherapy for Advanced Non-Small Cell Lung Cancer

Immunotherapy for Advanced Non-Small Cell Lung Cancer

Sukhmani K. Padda, MD

Updates in Immunotherapy for Lung Cancer

Updates in Immunotherapy for Lung Cancer

Sukhmani Padda (Stanford)

Lung Cancer

Sukhmani Padda (Stanford), Jonathan W. Riess (UCD), Ravi Salgia (COH), H. Jack West (COH)

Small Cell Lung Cancer: Novel Approaches

Small Cell Lung Cancer: Novel Approaches

Sukhmani Padda, MD

Locally Advanced NSCLC Chemotherapy / Targeted Therapy / Immunotherapy

Locally Advanced NSCLC Chemotherapy / Targeted Therapy / Immunotherapy

Surbhi Singhal, MD

«
1
…
81
82
83
84
85
…
115
»

Post navigation

← Previous View

6619 South Dixie Highway #341
Miami, FL 33143

Phone: 305.663.1628
Email: info@meccinc.com

Userful Links

Live Events

Categories

About Us

Why Subscribe
About Us
Accreditation

© 2025 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok